Patient-Reported and Functional Outcomes After Nonoperative Management of Minimally Displaced Femoral Neck Fractures

November 4, 2026 updated by: Henry Goodnough, Stanford University

Patient-Reported and Functional Outcomes After Nonoperative Management of Minimally Displaced Femoral Neck Fractures: A Prospective Cohort Study

The goal of this observational study is to understand how hip function changes over 24 months in adults with minimally displaced femoral neck fractures who are treated without surgery. The study will also describe outcomes for patients who receive surgery as part of their usual clinical care.

Participants will:

  • Receive treatment chosen through shared decision-making with their orthopaedic surgeon; the study will not change their clinical care.
  • Complete questionnaires about hip function, pain, quality of life, mobility, and daily activities.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
100

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients presenting to Stanford Health Care Emergency Department or Orthopaedic Trauma Clinic

Description

Inclusion Criteria:

  • Acute minimally displaced femoral neck fracture, valgus-impacted or nondisplaced
  • AO/OTA 31-B1 fracture pattern
  • Presentation within 7 days of injury

Exclusion Criteria:

  • Displaced femoral neck fracture
  • Pathologic fracture
  • Periprosthetic fracture
  • Open fracture
  • Previous ipsilateral femoral neck fracture
  • Previous isilateral hip arthroplasty
  • Polytrauma
  • Delayed presentation to ED

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Non-operative management group

Participants treated non-operatively for femoral neck fractures
Other: Non-operative management

Patient reported outcome measures and functional outcomes at 6 weeks, 4 months, 12 months and 24 months post injury
Operative management group

Participants treated operatively for femoral neck fractures
Procedure: Operative management

Patient reported outcomes and functional outcomes at 6 weeks, 4 months, 12 months, and 24 months post injury

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Changes in Modified Harris Hip Score
Time Frame: 6 weeks, 4 months, 12 months post injury

Changes from baseline to 12 months. The modified Harris Hip Score (mHHS) is a measure of physical function scored from 0 to 100, where higher scores indicate better physical function and lower scores indicate worse physical function.
6 weeks, 4 months, 12 months post injury

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Failure of non-operative management
Time Frame: 6 weeks, 4 months, 12 months, 24 months post injury

Failure rate of non-operative management defined as conversion to hemiarthroplasty, or total hip arthroplasty.
6 weeks, 4 months, 12 months, 24 months post injury
Changes in Oxford Hip Score
Time Frame: 6 weeks, 4 months, 12 months, 24 months post injury

Changes from baseline to 24 months. The Oxford Hip Score is a measure of physical function scored on the 0 to 48 scale. Each of the 12 items scored 0 to 4, higher scores indicating better physical function and lower scores indicate worse physical function.
6 weeks, 4 months, 12 months, 24 months post injury
Changes in health related quality of life
Time Frame: 6 weeks, 4 months, 12 months, 24 months post injury

Changes from baseline to 24 months in EQ-5D-5L. EQ-5D-5L is a patient reported outcome measure to measure health related quality of life scored on a 5 to 25 scale where higher scores indicate worse health status and lower scores indicates better health status.
6 weeks, 4 months, 12 months, 24 months post injury
Changes to Barthel Index
Time Frame: 6 weeks, 4 months, 12 months, 24 months post injury

Changes from baseline to 24 months. The Barthel index is a measure of a participant's level of functional independence in basic activities of daily living. It is scored on a 0-100 scale, where higher score indicating higher level of independence and lower score indicating higher level of dependence.
6 weeks, 4 months, 12 months, 24 months post injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Stanford University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 1, 2028

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 1, 2028

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 4, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 4, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
November 10, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
November 10, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 4, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 89044

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings